CA1337731C - Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule - Google Patents
Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette moleculeInfo
- Publication number
- CA1337731C CA1337731C CA000556648A CA556648A CA1337731C CA 1337731 C CA1337731 C CA 1337731C CA 000556648 A CA000556648 A CA 000556648A CA 556648 A CA556648 A CA 556648A CA 1337731 C CA1337731 C CA 1337731C
- Authority
- CA
- Canada
- Prior art keywords
- tetrapeptide
- subjecting
- reverse phase
- silica
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA000556648A CA1337731C (fr) | 1986-07-18 | 1988-01-15 | Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8610486A FR2601678B1 (fr) | 1986-07-18 | 1986-07-18 | Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie |
AU10261/88A AU598897B2 (en) | 1986-07-18 | 1988-01-14 | Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation, and its uses |
CA000556648A CA1337731C (fr) | 1986-07-18 | 1988-01-15 | Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule |
NO880186A NO173655C (no) | 1986-07-18 | 1988-01-18 | Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale |
NO930799A NO175102C (no) | 1986-07-18 | 1993-03-04 | Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1337731C true CA1337731C (fr) | 1995-12-12 |
Family
ID=27506551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000556648A Expired - Fee Related CA1337731C (fr) | 1986-07-18 | 1988-01-15 | Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1337731C (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130137637A1 (en) * | 2010-03-26 | 2013-05-30 | Samsungn Life Welfare Foundation | Peptides for promoting angiogenesis and an use thereof |
-
1988
- 1988-01-15 CA CA000556648A patent/CA1337731C/fr not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130137637A1 (en) * | 2010-03-26 | 2013-05-30 | Samsungn Life Welfare Foundation | Peptides for promoting angiogenesis and an use thereof |
US9610318B2 (en) * | 2010-03-26 | 2017-04-04 | Industry-Academic Cooperation Foundation, Sookmyung Women's University | Peptides for promoting angiogenesis and use thereof |
US9938320B2 (en) | 2010-03-26 | 2018-04-10 | Industry-Academic Cooperation Foundation, Sookmyung Women's University | Peptides for promoting angiogenesis and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4571336A (en) | Immune stimulation | |
US6239104B1 (en) | Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 | |
US4910296A (en) | Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin | |
CN100427502C (zh) | 抗肿瘤寡肽及其制备方法和应用 | |
US4612365A (en) | Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments | |
JPS60233098A (ja) | 抗凝固作用を有する新規ポリペプチド | |
CN104918951B (zh) | 多粘菌素、组合物、制备方法和使用方法 | |
JPS6222799A (ja) | 血液凝固阻害作用を有する新規ポリペプチド | |
US4470926A (en) | Medicaments containing thymosin alpha 1 fragments and having an immunostimulant action, and fragments of thymosin alpha 1 | |
US5114926A (en) | Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses | |
Reimer et al. | Small-scale solid-phase O-glycopeptide synthesis of linear and cyclized hexapeptides from blood-clotting factor IX containing O-(α-D-Xyl-1→ 3-α-D-Xyl-1→ 3-β-D-Glc)-L-ser | |
CZ287816B6 (en) | Peptide, process of its preparation, pharmaceutical preparation in which it is comprised and use thereof | |
Abiko et al. | Identification and synthesis of a heptapeptide in uremic fluid | |
EP0288965A2 (fr) | Peptides inhibant l'activité de phospholipase-A2 | |
CA1176193A (fr) | Peptide, procede de preparation et compose pharmaceutique le contenant | |
US4384991A (en) | Process for the preparation of a biologically active substance for selective inhibition of the proliferation of leukemic and normal myeloid cells | |
RU2141337C1 (ru) | Соединения на основе реакции амадори, их применение, способ получения и составы на их основе | |
EP0310887B1 (fr) | Peptide vaso-constricteur | |
CA1337731C (fr) | Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule | |
CN112851755B (zh) | 一种线性脂肽化合物及其制备方法与应用 | |
DK171969B1 (da) | Tetrapeptid, dets fremstilling og anvendelse | |
CN111603567A (zh) | Cd44靶向多臂偶联物 | |
US6015878A (en) | Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application | |
DE3781691T2 (de) | Tetrapeptid-hemmstoff zum eintritt in den kreislauf von hemopoietischen stammzellen, verfahren zu deren herstellung und deren anwendungen. | |
NO175102B (no) | Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |